期刊文献+

川芎嗪对溃疡性结肠炎肠粘膜过氧化物酶体增殖物激活受体γ及核因子κB的影响 被引量:3

Effect of Tetramethylpyrazine on the Expression of Peroxisome Proliferators-activated Receptor γ and Nuclear Factor-κB with Ulcerative Colitis
下载PDF
导出
摘要 目的:通过观测经川芎嗪治疗前后过氧化物酶体增殖物激活受体γ(PPARγ)、核因子κB(NF-κB)和肿瘤坏死因子(TNF)-α的变化,探讨川芎嗪治疗溃疡性结肠炎(UC)的作用机制。方法:以噁唑酮诱导小鼠UC模型,并随机分为实验对照组(CN)、模型组(OXZ)、川芎嗪治疗组(TMP)和0.9%氯化钠治疗对照组(NS)。观察UC炎症评价指标(DAI,大体、组织学损伤评分,MPO值);采用荧光定量PCR法检测各组肠粘膜PPARγ、NF-κBp65、TNF-αmRNA的表达量;免疫组化法检测PPARγ、NF-κBp65蛋白的表达。结果:与CN组比较,OXZ组的炎症评价指标均明显增高(P<0.01),PPARγ表达量明显下降(P<0.01)、NF-κBp65及TNF-α表达量均显著升高(P<0.01)。应用川芎嗪后,UC的炎症评价指标均较NS组明显降低(P<0.01),PPARγ表达量明显升高(P<0.01)、NF-κBp6及TNF-α表达量均下降(P<0.01)。结论:川芎嗪对UC的结肠粘膜有保护作用,其机制可能与PPARγ的激活,NF-κB的抑制,TNF-α等炎症因子表达的减低有关。 Objective:To investigate the role of PPAR γ、NF-κB and tμmor necrosis factor-α in the ulcerative colitis(UC)treatment by TMP.Methods:Mouse UC model was induced by oxazolone,and randomized to four groups:50% ethanol infused normal control group(NC),UC group(OXZ),TMP treat group(TMP) and NS treat group(NS).Disease active index(DAI),macroscopic and histological damage was observed and evaluated.Colonic MPO was measured by chemical method.The mRNA level of PPARγ,NF-κB p65 and TNF-α in colonic mucosa was quantitated by real-time PCR.The expression of PPARγ and NF-κB p65 were also detected by immunohistochemistry in protein level.Results:Oxazolone colitis was constructed successfully with marked inflammation in colonic mucosa examined macroscopically and histologically.Compared with those of the NC group,the expression of PPARγ was decreased in OXZ group but NF-κB p65,TNF-α were higher(P〈0.01).Both symptoms and the lesions of colonic mucosa were slighter in the animals treated with TMP than those of NS group(P〈0.01).And the expression of PPARγ was higher in TMP group than NS group(P〈0.01),but NF-κB p65 and TNF-α were decreased(P〈0.01).Conclusion:TMP has protective effect against mouse ulcerative colitis,and its mechanism may be related with the activation of PPARγ,inhibition of NF-κB activation,and reduction of TNF-α.
出处 《中国临床医学》 北大核心 2008年第3期341-343,共3页 Chinese Journal of Clinical Medicine
基金 上海市自然科学基金资助项目(05ZR14085)
关键词 溃疡性结肠炎 川芎嗪 过氧化物酶体增殖物激活受体Γ 核转录因子-ΚB 肿瘤坏死因子-α Ulcerative colitis Tetramethylpyrazine Peroxisome proliferators-activated receptor γ Nuclear factor-κB Tumor necrosis factor-α
  • 相关文献

参考文献9

  • 1Sanchez-Hidalgo M, Martin AR, Villegas I, et al. Rosiglita zone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats [J]. Eur J Pharmacol, 2007, 562(3): 247-258.
  • 2Luk HH, Ko JK, Fung HS, et al. Delineation of the protective action of zinc sulfate on ulcerative colitis in rats [J]. Eur J Pharmacol, 2002, 443(1-3): 197-204.
  • 3韩英,村田有志,伊东重豪,栋方昭博.长期应用尼古丁对恶唑酮诱导的实验性小鼠肠炎模型的影响及其机制探讨[J].中华消化杂志,2001,21(8):473-476. 被引量:39
  • 4Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis [J]. Gastroenterology, 2003, 124(5): 1265-1276.
  • 5梁红亮,欧阳钦.过氧化物酶体增生物激活受体-γ在小鼠噁唑酮结肠炎中作用的研究[J].胃肠病学,2007,12(2):101-105. 被引量:8
  • 6Ramakers JD, Verstege MI, Thuijls G, et al. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis [J]. J Clin Immunol, 2007, 27 (3): 275- 283.
  • 7Adachi M, Kurotani R, Morimura K, et al. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease [J]. Gut, 2006, 55(8): 1104-1113.
  • 8Andresen L, Jorgensen VL, Perner A, et al. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis [J]. Gut, 2005, 54(4): 503-509.
  • 9De Vry CG, Prasad S, Komuves L, et al. Non-viral delivery of nuelear faetor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis [J]. Gut, 2007, 56(4) : 524-533.

二级参考文献24

  • 1梁红亮,欧阳钦.罗格列酮联合氨基水杨酸治疗溃疡性结肠炎[J].中华内科杂志,2006,45(7):548-551. 被引量:26
  • 2Murata Y,Gastrointestinal Function,2000年,18卷,87页
  • 3Boirivant M,J Exp Med,1998年,188卷,1929页
  • 4Murata Y,J Gastroenterol,1995年,30卷,suppl 8期,56页
  • 5Heller F, Fuss IJ, Nieuwenhuis EE, et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis,is mediated by IL-13-producing NK-T cells. Immunity,2002, 17 (5): 629-638.
  • 6Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology,1990, 98 (3): 694-702.
  • 7Ekstrom GM. Oxazolone-induced colitis in rats: effects of budesonide, cyclosporin A, and 5-aminosalicylic acid.Scand J Gastroenterol, 1998, 33 (2): 174-179.
  • 8Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of maerophage activation. Nature, 1998, 391 (6662): 79-82.
  • 9Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology, 21303, 124(5): 1265-1276.
  • 10Lewis JD, Lichtenstein GR, Stein RB, et al. An openlabel trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol, 2001, 96(12): 3323-3328.

共引文献44

同被引文献39

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部